Nucleic Acids Research, Vol 27, Issue 8 1837-1846, Copyright © 1999 by Oxford University Press
F Coste, JM Malinge, L Serre, W Shepard, M Roth, M Leng and C Zelwer
cis-diamminedichloroplatinum (II) (cisplatin) is a powerful anti-tumor drug
whose target is cellular DNA. In the reaction between DNA and cisplatin,
covalent intrastrand and interstrand cross-links (ICL) are formed. Two
solution structures of the ICL have been published recently. In both models
the double-helix is bent and unwound but with significantly different angle
values. We solved the crystal structure at 100K of a double-stranded DNA
decamer containing a single cisplatin ICL, using the anomalous scattering
(MAD) of platinum as a unique source of phase information. We found 47
degrees for double-helix bending and 70 degrees for unwinding in agreement
with previous electrophoretic assays. The crystals are stabilized by
intermolecular contacts involving two cytosines extruded from the
double-helix, one of which makes a triplet with a terminal G.C pair. The
platinum coordination is nearly square and the platinum residue is embedded
into a cage of nine water molecules linked to the cross-linked guanines, to
the two amine groups, and to the phosphodiester backbone through other
water molecules. This water molecule organization is discussed in relation
with the chemical stability of the ICL.
ARTICLES
Crystal structure of a double-stranded DNA containing a cisplatin interstrand cross-link at 1.63 A resolution: hydration at the platinated site
Centre de Biophysique Moleculaire, Centre de National de la Recherche Scientifique, affiliated to the Universite d'Orleans, rue Charles Sadron, 45071 Orleans Cedex, France.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Chvalova, V. Brabec, and J. Kasparkova Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin Nucleic Acids Res., March 19, 2007; 35(6): 1812 - 1821. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Leonce, L. Kraus-Berthier, R. M. Golsteyn, M.-H. David-Cordonnier, C. Tardy, A. Lansiaux, V. Poindessous, A. K. Larsen, and A. Pierre Generation of replication-dependent double-strand breaks by the novel n2-g-alkylator s23906-1. Cancer Res., July 15, 2006; 66(14): 7203 - 7210. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. F. Edfeldt, E. A. Harwood, S. Th. Sigurdsson, P. B. Hopkins, and B. R. Reid Solution structure of a nitrous acid induced DNA interstrand cross-link Nucleic Acids Res., May 20, 2004; 32(9): 2785 - 2794. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. F. Edfeldt, E. A. Harwood, S. Th. Sigurdsson, P. B. Hopkins, and B. R. Reid Sequence context effect on the structure of nitrous acid induced DNA interstrand cross-links Nucleic Acids Res., May 20, 2004; 32(9): 2795 - 2801. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kasparkova, O. Novakova, V. Marini, Y. Najajreh, D. Gibson, J.-M. Perez, and V. Brabec Activation of Trans Geometry in Bifunctional Mononuclear Platinum Complexes by a Piperidine Ligand: MECHANISTIC STUDIES ON ANTITUMOR ACTION J. Biol. Chem., November 28, 2003; 278(48): 47516 - 47525. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Redon, S. Bombard, M.-A. Elizondo-Riojas, and J.-C. Chottard Platinum cross-linking of adenines and guanines on the quadruplex structures of the AG3(T2AG3)3 and (T2AG3)4 human telomere sequences in Na+ and K+ solutions Nucleic Acids Res., March 15, 2003; 31(6): 1605 - 1613. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kasparkova, J. Zehnulova, N. Farrell, and V. Brabec DNA Interstrand Cross-links of the Novel Antitumor Trinuclear Platinum Complex BBR3464. CONFORMATION, RECOGNITION BY HIGH MOBILITY GROUP DOMAIN PROTEINS, AND NUCLEOTIDE EXCISION REPAIR J. Biol. Chem., December 6, 2002; 277(50): 48076 - 48086. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hofr and V. Brabec Thermal and Thermodynamic Properties of Duplex DNA Containing Site-specific Interstrand Cross-link of Antitumor Cisplatin or Its Clinically Ineffective Trans Isomer J. Biol. Chem., March 23, 2001; 276(13): 9655 - 9661. [Abstract] [Full Text] [PDF] |
||||


